Elusys and U.S. Army extend biodefense collaboration
Elusys Therapeutics, Inc. announced that it has extended its Cooperative Research and Development Agreement (CRDA) with the United States Army Medical Research Institute of infectious diseases (USAMRIID). Under the agreement, both parties will continue to perform collaborative research to develop therapeutics against anthrax and other unspecified biowarfare agents, using Elusys' HP Antibody(TM) technology.
Elusys has received funding from the department of Defense and the National Institutes of Health to accelerate the development of Anthim and the HP Antibody technology. In total, the Company has received over $20 million from the U.S. Government for these programs.
According to the company, Anthim is a high-affinitymonoclonal antibody, targeting the anthrax toxin Protective Antigen, that has demonstrated significant efficacy against anthrax infection in lethal animal spore challenge studies. Further, Anthim has been demonstrated to be safe and well tolerated when administered with and without antibiotics in a human safety study. Anthim is being developed for prophylaxis and post-exposure treatment of inhalation anthrax.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Safety of nano silver in consumer products: many questions remain open - BfR Workshop confirms incomplete data situation concerning the health risks of nanoscale silver
Seminal_vesicle
New Technology Development Grants Will Aid Quest To Find All Functional Elements in Human DNA - ENCODE Consortium Publishes Scientific Strategy
Cicuta
New key players found in fighting fungi - Important element of immune defense against fungal infections discovered
Trama
MU researcher uses bacteria to make radioactive metals inert - Scientist is studying bacteria that could clean contaminated water bodies across the US
